Medicines Formulary

Medicines A–Z

C

Status	Drug name	NICE TAs	Comments
	Coal tar BP 10% w/w in Yellow Soft Paraffin		Unlicensed special
	Coal tar BP 2% w/w in Yellow Soft Paraffin		Unlicensed special
	Coal tar BP 5% w/w in Yellow Soft Paraffin		Unlicensed special
	Coal tar solution BP 3.3% w/w and propylene glycol 20% w/w in Synalar® gel		Unlicensed special
	Coal tar solution BP 5% w/w in betamethasone valerate 0.025% w/w ointment		Unlicensed special
	Coal tar solution BP 6% w/w / salicylic acid 2% w/w in emulsifying ointment		Unlicensed special
	Coal tar solution BP 6% w/w and salicylic acid 6% w/w in Ung. merck		Unlicensed special
	Co-amilofruse tablets		Combination products should be avoided, unless compliance is an issue
	Co-beneldopa capsules
	Co-beneldopa dispersible tablets

First page
Previous page
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
Next page
Last page

Drug status key

Formulary drugs are allocated a traffic light status. This provides guidance on where clinical and prescribing responsibilities lie in regard to the initiation and maintenance of prescribing.

Grey

Positive NICE TA and/or awaiting local clarification on place in therapy. Please contact your medicines optimisation team for more information.

Red

Initiation and maintenance of prescribing by specialists only.

Amber

Initiation and maintenance of prescribing by specialists and transfer to primary care prescribing when appropriate, or in primary care following a specialists recommendation. Prior to initiation some medicines may require committee agreement or a framework to support safe transfer and maintenance.

Green

Initiation and maintenance of prescribing by specialists, GPs and other qualified clinicians.

Blue

Under review at University Hospitals Birmingham NHS Foundation Trust.